Publications by authors named "D L Uden"
Background: Individual risk prediction of 5-year locoregional recurrence (LRR) and contralateral breast cancer (CBC) supports decisions regarding personalised surveillance. The previously developed INFLUENCE tool was rebuild, including a recent population and patients who received neoadjuvant systemic therapy (NST).
Methods: Women, surgically treated for nonmetastatic breast cancer, diagnosed between 2012 and 2016, were selected from the Netherlands Cancer Registry.
Background: Value-based healthcare (VBHC) is increasingly implemented in healthcare worldwide. Transparent measurement of the outcomes most important and relevant to patients is essential in VBHC, which is supported by a core set of most important quality indicators and outcomes. Therefore, the aim of this study was to develop a VBHC-burns core set for adult burn patients.
View Article and Find Full Text PDFPurpose: Breast cancer follow-up (surveillance and aftercare) varies from one-size-fits-all to more personalised approaches. A systematic review was performed to get insight in existing evidence on (cost-)effectiveness of personalised follow-up.
Methods: PubMed, Scopus and Cochrane were searched between 01-01-2010 and 10-10-2022 (review registered in PROSPERO:CRD42022375770).
For deep partial-thickness burns no consensus on the optimal treatment has been reached due to conflicting study outcomes with low quality evidence. Treatment options in high- and middle-income countries include conservative treatment with delayed excision and grafting if needed; and early excision and grafting. The majority of timing of surgery studies focus on survival rather than on quality of life.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the differences in innate lymphoid cell (ILC) populations, specifically ILC1s and ILC2s, between patients with COPD (Chronic Obstructive Pulmonary Disease), asthma, and control groups.
- Results show significantly higher levels of inflammatory CD4 ILC1s and lower levels of CD117 ILC2s in COPD patients compared to asthma patients, highlighting distinct inflammatory profiles.
- These findings could help in understanding the mechanisms of COPD and asthma, potentially aiding in better patient classification and treatment strategies.